Breast Carcinoma-Amplified Sequence 2 (BCAS2) is a member of the SPF27 family. BCAS2 is a nuclear protein and widely expressed in many rtissues. BCAS2 is identified as being overexpressed in various breast cancer cell lines. BCAS2 is a component of the spliceosome, taking part in the removal of introns from mRNA precursors. BCAS2 interacts with estrogen receptor alpha and beta, thyroid hormone receptor beta, peroxisome proliferator-activated receptor gamma. BCAS2 functions as an ER co-activator and is capable of enhancing ER-mediated transcription.
Confezionamento: Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 200mM NaCl, 2mM DTT, pH 8.0.<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.
Stoccaggio: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Simbolo target: BCAS2;DAM1
Ig target: BCAS2;Breast Carcinoma-Amplified Sequence 2;DAM1;DNA Amplified in Mammary Carcinoma 1 Protein;Pre-mRNA-Splicing Factor SPF27;Spliceosome-Associated Protein SPF 27
Area di ricerca:Tags & Cell Markers;epigenetics and nuclear signal
Newsletter TEMA RICERCA
Ricevi aggiornamenti davvero rilevanti per il tuo ambito
Lascia la tua email e seleziona le aree che vuoi seguire per ricevere novita di prodotto, approfondimenti tecnici e promozioni piu pertinenti.
Puoi scegliere le macro-aree Life Science e Diagnostica oppure le singole specializzazioni.
Comunicazioni piu in linea con il tuo lavoro.
Novita e promozioni subito leggibili.
Selezione rapida tra aree principali e focus specifici.